Abstract
CAMPSIITE™ phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have